The veterinary rapid test market in North America is expected to grow from US$ 258.39 million in 2021 to US$ 461.52 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. An increase is zoonotic diseases is likely to drive the veterinary rapid test market. Animals can sometimes carry harmful germs that can spread to people and cause illness; these are known as zoonotic diseases or zoonoses. Zoonotic diseases are caused by harmful germs like bacteria, viruses, parasites, and fungi. These germs can cause many different types of illnesses in people and animals, ranging from mild to severe illness and even death. As per CDC, it estimates that more than six out of every ten known infectious diseases in people can be spread from animals and three out of every four new or upcoming infectious diseases in people come from animals. Outbreaks such as severe acute respiratory syndrome (SARS) and avian influenza have shown once again the potential of microorganisms from animal reservoirs to adapt to human hosts. During the past decades, many earlier unknown human infectious diseases have emerged from animal reservoirs, from agents such as Ebola virus, human immunodeficiency virus (HIV), Nipah virus, West Nile virus, and Hantavirus. More than three-quarters of the human diseases that are new, emerging, or re-emerging at the beginning of the 21st century are caused by pathogens which are originated from animals or products of animal origin. According to WHO, it is estimated that, some 60% of emerging infectious diseases that are reported are zoonoses and about one billion cases of illness and millions of deaths occur every year from zoonoses. Over 30 new human pathogens have been detected in the last three decades, 75% of which have originated in animals. Hence, emerging, and re-emerging zoonotic diseases will become a progressively more significant factor in the demand for veterinary rapid testing and has triggered companies to produce advanced diagnostic kits, which is contributing to the growth of the overall market for veterinary rapid testing.
The outbreak of COVID-19 has impacted all the industries including veterinary sector. There was an increase in pet adoption reported due to social isolation. For instance, shelters, nonprofit rescues, private breeders all reported high consumer demand during COVID 19 in the US. Most of the consumers in the market grappled with the onset of the pandemic. The retail e-commerce platforms witnessed high growth due to several restrictions on the brick-and-mortar stores and the disruption of the overall supply channel. Sales have spiked for pet care products at home, driven by the closure of veterinary clinics. Also, the pet population has increased in the region because of lockdown and people wanting a companion. Home isolation have driven the short-term pet fostering programs that may translate into long-term pet population growth in the future. Despite some disruptions caused by COVID-19 containment measures, the long-term growth potential of the sector remains intact. Also, the COVID-19 pandemic has highlighted the adaptability and response by veterinary diagnosticians to an emerging infectious disease and their role in maintaining animal health and protecting human public health. In addition, the market players have witnessed rise in sales. For instance, IDEXX’s companion animal group (CAG) diagnostics revenue increased by 23% in Q3 2020 as compared to last year. The recent surge in ownership, driven by an increase in adoption and fostering by people confined to their homes, offers lucrative opportunities for the growth of the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive veterinary rapid test market. The North America veterinary rapid test market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Veterinary Rapid Test Market Segmentation
North America Veterinary Rapid Test Market – By Product
- Rapid Test Kits
- Rapid Test Readers
North America Veterinary Rapid Test Market – By Application
- Viral Diseases
- Bacterial Diseases
- Parasitic Diseases
- Allergies
- Other Applications
North America Veterinary Rapid Test Market – By Animal Type
- Livestock Animals
- Cattle
- Poultry
- Swine
- Others
- Companion Animals
- Dogs
- Cats
- Horses
- Others
North America Veterinary Rapid Test Market- By Country
- US
- Canada
- Mexico
North America Veterinary Rapid Test Market-Companies Mentioned
- HESKA CORPORATION
- IDEXX LABORATORIES, INC.
- Virbac
- Woodley Equipment Company Ltd
- Zoetis Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Veterinary Rapid Test Market – By Product
1.3.2 North America Veterinary Rapid Test Market – By Application
1.3.3 North America Veterinary Rapid Test Market – By Animal Type
1.3.4 North America Veterinary Rapid Test Market – By Country
2. Veterinary Rapid Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Veterinary Rapid Test Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinions
5. North America Veterinary Rapid Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising incidences of zoonotic diseases
5.1.2 Increase in initiatives by the governments and animal welfare associations of different countries
5.2 Market Restraints
5.2.1 Limited Number of Skilled Professionals in Veterinary Diagnostics
5.3 Market Opportunities
5.3.1 Demand for Advanced Diagnostics to Improve Veterinary Disease Diagnosis
5.4 Future Trends
5.4.1 Escalating Number of Product Launches
5.5 Impact Analysis
6. Veterinary Rapid Test Market – North America Analysis
6.1 North America Veterinary Rapid Test Market Revenue Forecast and Analysis
7. North America Veterinary Rapid Test Market Analysis – By Product
7.1 Overview
7.2 North America Veterinary Rapid Test Market Revenue Share, by Product (2021 and 2028)
7.3 Rapid Test Kits
7.3.1 Overview
7.3.2 Rapid Test Kits: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Rapid Test Readers
7.4.1 Overview
7.4.2 Rapid Test Readers: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Veterinary Rapid Test Market Analysis – By Application
8.1 Overview
8.2 Veterinary Rapid Test Market Share, by Application, 2021 and 2028, (%)
8.3 Viral Diseases
8.3.1 Overview
8.3.2 Viral Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Bacterial Diseases
8.4.1 Overview
8.4.2 Bacterial Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parasitic Diseases
8.5.1 Overview
8.5.2 Parasitic Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Allergies
8.6.1 Overview
8.6.2 Allergies: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Application
8.7.1 Overview
8.7.2 Other Application: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Veterinary Rapid Test Market Analysis – By Animal Type
9.1 Overview
9.2 Veterinary Rapid Test Market Revenue Share, by Animal Type (2021 and 2028)
9.3 Companion Animals
9.3.1 Overview
9.3.2 Companion Animals: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
9.3.2.1 Dogs
9.3.2.1.1 Overview
9.3.2.1.2 Dogs Market Revenue and Forecast to 2028 (US$ Mn)
9.3.2.2 Cats
9.3.2.2.1 Overview
9.3.2.2.2 Cats Market Revenue and Forecast to 2028 (US$ Mn)
9.3.2.3 Horses
9.3.2.3.1 Overview
9.3.2.3.2 Horses Market Revenue and Forecast to 2028 (US$ Mn)
9.3.2.4 Others
9.3.2.4.1 Overview
9.3.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Livestock Animals
9.4.1 Overview
9.4.2 Livestock Animals: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
9.4.2.1 Cattle
9.4.2.1.1 Overview
9.4.2.1.2 Cattle Market Revenue and Forecast to 2028 (US$ Mn)
9.4.2.2 Swine
9.4.2.2.1 Overview
9.4.2.2.2 Swine Market Revenue and Forecast to 2028 (US$ Mn)
9.4.2.3 Poultry
9.4.2.3.1 Overview
9.4.2.3.2 Poultry Market Revenue and Forecast to 2028 (US$ Mn)
9.4.2.4 Others
9.4.2.4.1 Overview
9.4.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Veterinary Rapid Test Market – Country Analysis
10.1.1 Overview
10.1.2 North America: Veterinary Rapid Test Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Veterinary Rapid Test Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Veterinary Rapid Test Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Veterinary Rapid Test Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 US: Veterinary Rapid Test Market, by Animal Type, 2019–2028 (USD Million)
10.1.2.1.4.1 US: Veterinary Rapid Test Market, by Livestock Animals, 2019–2028 (USD Million)
10.1.2.1.4.2 US: Veterinary Rapid Test Market, by Companion Animals, 2019–2028 (USD Million)
10.1.2.2 Canada: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Veterinary Rapid Test Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Veterinary Rapid Test Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Veterinary Rapid Test Market, by Animal Type, 2019–2028 (USD Million)
10.1.2.2.4.1 Canada: Veterinary Rapid Test Market, by Livestock Animals, 2019–2028 (USD Million)
10.1.2.2.4.2 Canada: Veterinary Rapid Test Market, by Companion Animals, 2019–2028 (USD Million)
10.1.2.3 Mexico: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Veterinary Rapid Test Market, by Product – 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Veterinary Rapid Test Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Veterinary Rapid Test Market, by Animal Type, 2019–2028 (USD Million)
10.1.2.3.4.1 Mexico: Veterinary Rapid Test Market, by Livestock Animals, 2019–2028 (USD Million)
10.1.2.3.4.2 Mexico: Veterinary Rapid Test Market, by Companion Animals, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Veterinary Rapid Test Market
11.1 Overview
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 IDEXX LABORATORIES, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Zoetis Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Virbac
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 HESKA CORPORATION
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Woodley Equipment Company Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Veterinary Rapid Test Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US Veterinary Rapid Test Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. US Veterinary Rapid Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Veterinary Rapid Test Market, by Animal Type– Revenue and Forecast to 2028 (USD Million)
Table 5. US Veterinary Rapid Test Market, by Livestock Animals – Revenue and Forecast to 2028 (USD Million)
Table 6. US Veterinary Rapid Test Market, by Companion Animals – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Veterinary Rapid Test Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Veterinary Rapid Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Veterinary Rapid Test Market, by Animal Type– Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Veterinary Rapid Test Market, by Livestock Animals – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Veterinary Rapid Test Market, by Companion Animals – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Veterinary Rapid Test Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Rapid Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Veterinary Rapid Test Market, by Animal Type– Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Veterinary Rapid Test Market, by Livestock Animals – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Veterinary Rapid Test Market, by Companion Animals – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, North America Veterinary Rapid Test Market
LIST OF FIGURES
Figure 1. North America Veterinary Rapid Test Market Segmentation
Figure 2. North America Veterinary Rapid Test Market Segmentation, By Country
Figure 3. North America Veterinary Rapid Test Market Overview
Figure 4. Rapid Test Kits Segment Held Largest Share of North America Veterinary Rapid Test Market
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Veterinary Rapid Test Market Impact Analysis of Driver and Restraints
Figure 8. North America Veterinary Rapid Test Market – Revenue Forecast and Analysis to 2028
Figure 9. North America Veterinary Rapid Test Market Revenue Share, by Product (2021 and 2028)
Figure 10. North America Rapid Test Kits: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Rapid Test Readers: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Veterinary Rapid Test Market Share, by Application, 2021 and 2028 (%)
Figure 13. North America Viral Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Bacterial Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Parasitic Diseases: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Allergies: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Other Application: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Veterinary Rapid Test Market Revenue Share, by Animal Type (2021 and 2028)
Figure 19. North America Companion Animals: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Dogs Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Cats Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. North America Horses Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Livestock Animals: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Cattle Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Swine Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. North America Poultry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. North America: Veterinary Rapid Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. North America: Veterinary Rapid Test Market, by Country, 2021 & 2028 (%)
Figure 31. US: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Veterinary Rapid Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in North American Country Markets
- HESKA CORPORATION
- IDEXX LABORATORIES, INC.
- Virbac
- Woodley Equipment Company Ltd
- Zoetis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Veterinary Rapid Test Market
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2021